Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus
Clinical trial NCT04260594 · COMPLETED
Trial details
- NCT number
- NCT04260594
- Sponsor
- Jieming QU
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-08
- Primary completion
- 2020-03-12
- Enrollment
- 236
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.